Integra LifeSciences Holdings Corporation Stock
Stocks
IART
US4579852082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 15.50 USD | -0.26% |
|
-7.30% | +24.80% |
| 07-30 | BMO Cuts Price Target on Integra LifeSciences Holdings to $18 From $19, Keeps Market Perform Rating | MT |
| 07-29 | Integra LifeSciences Holdings Corporation, Q2 2026 Earnings Call, Jul 29, 2026 |
| Market Cap | 1.21B 1.04B 984M 892M 1.67B 115B 1.68B 11.65B 4.49B 58.54B 4.53B 4.43B 185B | P/E 2026 * |
24.2x | P/E 2027 * | 12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 2.69B 2.32B 2.2B 1.99B 3.74B 257B 3.76B 26.04B 10.04B 131B 10.12B 9.9B 413B | EV / Sales 2026 * |
1.61x | EV / Sales 2027 * | 1.44x |
| Free-Float |
72.35% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IART | Delayed | |
CBOE
| IART | Real-time | |
Deutsche Boerse AG
| IL3 | Delayed | |
Börse Stuttgart
| IL3 | Delayed | |
Boerse Muenchen
| IL3 | Real-time | |
Tradegate
| IL3 | Real-time | |
Berne S.E.
| IL3 | End-of-day quote |
Last Transcript : Integra LifeSciences Holdings Corporation
| 1 day | -0.26% | ||
| 1 week | -7.30% | ||
| Current month | -8.39% | ||
| 1 month | -10.82% | ||
| 3 months | -12.77% | ||
| 6 months | +69.03% | ||
| Current year | +24.80% |
| 1 week | 15.33 | 16.55 | |
| 1 month | 15.33 | 18.45 | |
| Current year | 8.7 | 20.49 | |
| 1 year | 8.7 | 20.49 | |
| 3 years | 8.7 | 45.42 | |
| 5 years | 8.7 | 74.98 | |
| 10 years | 8.7 | 77.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stuart Essig
CEO | Chief Executive Officer | 64 | 2026-04-30 |
Lea Knight
DFI | Director of Finance/CFO | 54 | 2023-06-27 |
Teshtar Elavia
CTO | Chief Tech/Sci/R&D Officer | - | 2026-02-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Stuart Essig
CHM | Chairman | 64 | 2012-01-02 |
Keith Bradley
BRD | Director/Board Member | 81 | 1991-12-31 |
Christian Schade
BRD | Director/Board Member | 65 | 2005-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Tax | Head of Human Resources | -1,455 | 0.0019% | ||
| 7/3/26 | Tax | Chief Financial Officer | -5,226 | 0.0067% | ||
| 7/1/26 | Free | Executive/Senior Manager | 5,590 | 0.0072% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.26% | -7.30% | +2.92% | -60.38% | 1.21B | ||
| -1.36% | -5.89% | -23.76% | -0.44% | 176B | ||
| -0.72% | -3.41% | -3.26% | +12.32% | 116B | ||
| +0.19% | -2.83% | +6.30% | +80.17% | 61.36B | ||
| -1.92% | -6.01% | +7.05% | +38.44% | 49.42B | ||
| +0.81% | -3.73% | -4.81% | -32.56% | 48.44B | ||
| -1.75% | -5.54% | +8.93% | -20.82% | 31.33B | ||
| +0.43% | -11.10% | - | - | 28.54B | ||
| +0.58% | +1.84% | +36.58% | -12.08% | 24.37B | ||
| +0.49% | -7.65% | -13.30% | +3.79% | 21.57B | ||
| Average | -0.35% | -5.30% | +1.85% | +0.94% | 55.9B | |
| Weighted average by Cap. | -0.69% | -4.90% | -6.00% | +10.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.67B 1.44B 1.37B 1.24B 2.32B 160B 2.34B 16.18B 6.24B 81.32B 6.29B 6.15B 257B | 1.73B 1.49B 1.41B 1.28B 2.4B 165B 2.41B 16.69B 6.44B 83.9B 6.49B 6.34B 265B |
| Net income | 42.03M 36.25M 34.31M 31.09M 58.29M 4.02B 58.68M 406M 157M 2.04B 158M 154M 6.45B | 78.69M 67.87M 64.24M 58.2M 109M 7.52B 110M 760M 293M 3.82B 295M 289M 12.07B |
| Net Debt | 1.49B 1.28B 1.22B 1.1B 2.07B 142B 2.08B 14.39B 5.55B 72.33B 5.59B 5.47B 228B | 1.28B 1.11B 1.05B 950M 1.78B 123B 1.79B 12.42B 4.79B 62.4B 4.82B 4.72B 197B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | US$15.50 | -0.26% | 792,028 |
| 26-09-10 | US$15.54 | -4.37% | 1,361,972 |
| 26-09-09 | US$16.25 | -0.06% | 578,400 |
| 26-09-08 | US$16.26 | -2.75% | 621,796 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IART Stock
Select your edition
All financial news and data tailored to specific country editions

















